Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Cladribine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 14,695Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bionxt Secures Eurasian Patent For Sublingual MS Therapy
    Bionxt Secures Eurasian Patent For Sublingual MS Therapy

    24 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/bionxt-secures-eurasian-patent-for-breakthrough-sublingual-ms-therapy-18336

    INDPHARMAPOST
    24 Nov 2025
    Share Share
    EMD Serono Innovates Rare Neuromuscular Disorder Treatment
    EMD Serono Innovates Rare Neuromuscular Disorder Treatment

    24 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251124788420/en/EMD-Serono-Takes-Patient-Directed-Approach-to-Bring-Innovation-to-the-Treatment-of-Rare-Neuromuscular-Disorder-Generalized-Myasthenia-Gravis

    BUSINESSWIRE
    24 Nov 2025
    Share Share
    Bionxt Secures Eurasian Patent For Sublingual Cladribine Platform
    Bionxt Secures Eurasian Patent For Sublingual Cladribine Platform

    20 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-20/bionxt-secures-final-patent-grant-from-the-eurasian-patent-organization-for-sublingual-cladribine-pl

    PHARMIWEB
    20 Nov 2025
    Share Share
    BioNxt Gets EPO Intention to Grant for Oral Cladribine Film
    BioNxt Gets EPO Intention to Grant for Oral Cladribine Film

    04 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-04/bionxt-reports-intention-to-grant-patent-notification-from-the-european-patent-office-for-its-oral

    PHARMIWEB
    04 Nov 2025
    Share Share
    BioNxt Gets Eurasian Patent Readiness to Grant Notification
    BioNxt Gets Eurasian Patent Readiness to Grant Notification

    30 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-30/bionxt-reports-readiness-to-grant-patent-notification-from-the-eurasian-patent-organization

    PHARMIWEB
    30 Oct 2025
    Share Share
    Bionxt Nears Human Trials For Advanced MS Drug
    Bionxt Nears Human Trials For Advanced MS Drug

    23 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bionxt-enters-the-final-stretch-before-human-trials-for-next-generation-ms-drug-302592654.html

    PR NEWSWIRE
    23 Oct 2025
    Share Share